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Cells synthesize the GPI anchor carbohydrate core by suc-
cessively adding N-acetylglucosamine, three mannoses, and
phosphoethanolamine (EtN-P) onto phosphatidylinositol,
thus forming the complete GPI precursor lipid which is then
added to proteins. Previously, we isolated a GPI deficient
yeast mutant accumulating a GPI intermediate containing
only two mannoses, suggesting that it has difficulty in adding
the third, α1,2-linked Man of GPI anchors. The mutant thus
displays a similar phenotype as the mammalian mutant cell
line S1A-b having a mutation in the PIG-B gene. The yeast
mutant, herein named gpi10–1, contains a mutation in
YGL142C, a yeast homolog of the human PIG-B. YGL142C
predicts a highly hydrophobic integral membrane protein
which by sequence is related to ALG9, a yeast gene required
for adding Man in α1,2 linkage to N-glycans. Whereas
gpi10–1 cells grow at a normal rate and make normal
amounts of GPI proteins, the microsomes of gpi10–1 are com-
pletely unable to add the third Man in an in vitro assay.
Further analysis of the GPI intermediate accumulating in
gpi10 shows it to have the structure Manα1–6(EtN-
P-)Manα1–4GlcNα1–6(acyl)Inositol-P-lipid. The presence of
EtN-P on the α1,4-linked Man of GPI anchors is typical of
mammalian and a few other organisms but had not been ob-
served in yeast GPI proteins. This additional EtN-P is not
only found in the abnormal GPI intermediate of gpi10–1 but
is equally present on the complete GPI precursor lipid of wild
type cells. Thus, GPI biosynthesis in yeast and mammals pro-
ceeds similarly and differs from the pathway described for
Trypanosoma brucei in several aspects.
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Introduction
Many glycoproteins of lower and higher eukaryotes are attached
to the plasma membrane by means of a glycosylphosphatidyli-
nositol (GPI) (Englund, 1993; McConville and Ferguson, 1993).
Where investigated, the GPI anchoring pathway has been found
to be essential. In man, somatic mutations in the GPI anchoring
pathway of hematopoietic stem cells cause a hemolytic disease
called paroxysmal nocturnal hemoglobinuria. Similarly, targeted
deletion of the GPI pathway in the mouse model shows that the
pathway is of vital importance for fetal and neonatal development
(Dunn et al., 1996; Kawagoe et al., 1996; Tarutani et al., 1997).
GPI anchoring also is essential for Saccharomyces cerevisiae
(Leidich et al., 1994, 1995; Hamburger et al., 1995; Schönbächler
et al., 1995; Vossen et al., 1995) since many cell wall proteins are
primarily anchored via a GPI (de-Nobel and Lipke, 1994;
Van-der-Vaart et al., 1997).
GPI proteins have a classical signal sequence at their
N-terminus and a GPI anchoring signal at their C-terminus, which
latter, after import of the protein into the ER, is removed and
replaced by a preformed GPI (Caras et al., 1987; Moran and
Caras, 1991; Moran et al., 1991; Kodukula et al., 1993).
GPI anchor biosynthesis seems to have been elaborated early
in evolution since the oligosaccharide core linking the protein to
the lipid moiety has the same structure in all organisms analyzed
so far, namely protein-CO-NH-(CH2)2-PO4–6Manα1–2Manα1–
6Manα1–4GlcNH2-myo-inositol-PO4-lipid. Apart from this
carbohydrate core, GPI anchors from various species differ
widely by the kind of side chains attached to the core structure and
by their lipid moieties (McConville and Ferguson, 1993).
One characteristic side chain described in mammals and also
in Torpedo californica consists of a phosphoethanolamine
(EtN-P) attached to the C2 position of the α1,4-linked Man
(Man1, Figure 1). As for many other side chains, no functional
role has been attributed yet to this modification. The previous
structural analysis of mature yeast GPI proteins did not reveal the
presence of this EtN-P residue (Fankhauser et al., 1993).
However, while analyzing the structure of an abnormal glycolipid
accumulating in mutant 839 (Benghezal et al., 1995) we realized
that it carried an EtN-P and has the structure Manα1–6(EtN-
P-)Manα1–4GlcNα1–6(acyl)Ins-P-lipid. This finding was quite
unexpected and triggered further investigations which revealed
that the EtN-P substituent on Man1 was also present on the
complete GPI precursor lipid (CP2) ready to be transferred to
proteins, whereas the incomplete GPI intermediate of mutant 839
could not be linked up to proteins.
We also report on the further characterization of mutant 839 and
show that its GPI deficiency is due to a mutation in YGL142C, a
predicted open reading frame of S.cerevisiae which has homology
to PIG-B (Takahashi et al., 1996). PIG-B is a human gene which,
if mutated, also causes the accumulation of the same
Manα1–6(EtN-P-)Manα1–4GlcNα1–6(acyl)Ins-P-lipid inter-
mediate (Puoti et al., 1991; Takahashi et al., 1996).
Results
M2* accumulation of strain 839 segregates as a Mendelian
recessive trait and can be corrected by YGL142C
We recently reported on the isolation of yeast mutants deficient
in the biosynthesis of GPI anchors (Benghezal et al., 1995).
Mutant 839 accumulated M2*, an abnormal, incomplete GPI
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Fig. 1. Presumed structure of the complete yeast precursor glycolipid CP2.
Relevant cleavage procedures are indicated. Man1, Man2, Man3, and Man4
will be used in the text to designate the α1,4-linked, α1,6-linked, and
α1,2-linked Man, respectively.
containing a Man2-GlcN-Ins carbohydrate core but still incorpo-
rated some [3H]Ins into proteins and thus was still able to make
GPI proteins at 37C. 839 was sterile but could be out crossed to
X2180–1A by spheroplast fusion, and M2* accumulating spores
were then back crossed twice to W303. In the last back cross the
M2* accumulation segregated in a 2:2 manner in 4 out of 4 tetrads
and was no more associated with sterility nor with the slight ts
growth phenotype of the original mutant. M2* accumulating
strains were named gpi10–1. After crossing the gpi10–1 mutants
incorporated perfectly normal amounts of [3H]Ins into proteins.
We could suppress M2* accumulation by transfecting a multi-
copy plasmid with YGL142C, a yeast open reading frame which
is homologous to the human PIG-B gene (30.5% identity, 57.4%
similarity) as shown in Figure 2, lane 2. When the URA3-based
YGL142C-containing plasmid was forced out again with 5
fluoroorotic acid, M2* accumulation reappeared (Figure 2, lane
3). YGL142C on a single copy vector greatly reduced M2*
accumulation (Figure 2, lane 4). When the gene was integrated
into the genome, the accumulation of this intermediate was no
more observed (lane 5). Sequencing of YGL142C and its flanking
regions in gpi10–1 revealed the presence of a single point
mutation consisting of a G to A transition which changes Ala48
into Thr. Ethylmethanesulfonate, by which the mutant was
generated, almost exclusively produces GC to AT transitions
(Kohalmi and Kunz, 1988).
Microsomes of wild type cells make complete GPIs in vitro
To further characterize the defect of 839 we used a previously
described microsomal in vitro system (Costello and Orlean, 1992)
transferring [3H]GlcNAc from UDP-[3H]GlcNAc to PI, thus
generating [3H]GlcNAc-PI, [3H]GlcN-PI and [3H]GlcN-
(acyl)PI. As reported previously (Costello and Orlean, 1992), the
addition of ATP and Coenzyme A greatly enhanced the produc-
tion of [3H]GlcN-(acyl)PI (not shown). In the presence of
GDP-Man wild type microsomes made several additional lipid
species (Figure 3A), the most polar of which (lipid k) comigrated
with the complete GPI precursor CP2 (Figure 3A, lanes 2, 3). No
additional bands were observed when tunicamycin was omitted
and the addition of the chitin synthase inhibitor nikkomycin did
not increase the incorporation of [3H]GlcNAc into lipids (not
shown). All lipids made by the microsomes were purified by two
rounds of preparative TLC, their head groups were dephosphory-
lated by HF, N-acetylated, desalted and finally analyzed by TLC
as described previously (Sipos et al., 1994). This allowed to
define the number of Man residues attached to the GlcN-Ins core
Fig. 2. Complementation of gpi10–1 by YGL142C. 2.5 OD600 of FBY169
cells containing different plasmids were labeled at 37C in SDCA medium
using 2 µCi [2–3H]Ins/OD600 unit of cells. The lipids were extracted and
analyzed by TLC using solvent 2. 5-FOA, 5 fluoroorotic acid was used to
select against plasmid pBF61 of the strain shown in lane 2. pBF64 has no
ARS sequence and can only be inherited after integration into the genome.
O, Origin.
of these intermediates (Figure 3 caption). Lipids h, i, j, and k
contained four Man residues. We sought further confirmation that
lipid k was indeed identical with CP2, i.e., the most polar
complete GPI precursor generated in vivo (Sipos et al., 1994). For
this the lipid extract of labeled microsomes was treated with
PI-PLC and with jack bean α-mannosidase (JBAM). Lipid k was
found to be resistant to PI-PLC whereas the nonacylated
GlcNAc-PI and GlcN-PI were not (Figure 3A, lane 3). Lipid k
also was transformed into a lipid with a slightly higher Rf by
JBAM (lane 4) and was quantitatively cleaved by GPI-PLD (not
shown). Thus, the partial structural analysis shows that lipid k
behaves in all respects as the authentic CP2 of intact cells (Sipos
et al., 1994). Since the microsomal system used here does not
support vesicular traffic, the result demonstrates, that all the
enzymes required to make CP2 are contained in the ER.
Biosynthesis of complete GPI precursors was previously
observed to be dependent on the addition of GDP-Man in the
analogous system from T.brucei (Masterson et al., 1989; Menon
et al., 1990). It thus appears that in both yeast and trypanosomal
microsomes the obligatory intermediate Dol-P-Man is limiting
but can be replenished by the addition of GDP-Man.
Phosphoethanolamine side chain in yeast GPI glycolipids
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Fig. 3. Incorporation of UDP-[3H]GlcNAc into GPIs by microsomes in vitro. (A) Microsomes of W303 wild type cells were incubated with 6 µCi of
UDP-[3H]GlcNAc, tunicamycin, nikkomycin and ATP, in presence (+) or absence (-) of GDP-Man for 1 h at 37C. The glycolipid products were extracted and
separated by TLC. (B) W303 wild type and 839 cells were labeled with [3H]Ins (lanes 5, 6) and their microsomes were labeled with UDP-[3H]GlcNAc in the
presence of GDP-Man (lanes 7–9). The number of Man residues attached to the GlcN-Ins core of lipids a–k was found to be 0 for a, c and d; 1 for b and e; 4 for
h, i, j, and k. Bands f and g contained mixtures: 0 or 1 Man in band f, 1 or 2 Man in band g. The most polar UDP-[3H]GlcNAc-labeled lipid of 839 comigrating
with f is labeled f′.
Microsomes of 839 are unable to make complete GPIs in vitro
For further characterization of the mutation in 839, we assayed
the ability of its microsomes to synthesize GPI precursor lipids in
vitro. Under conditions in which wild type microsomes made
CP2, mutant microsomes made abnormally high amounts of a
less polar species (Figure 3B, lane 9, band f′) but none of the more
polar species. Lipid f′ comigrated with the [3H]Ins labeled
abnormal GPI lipid M2* accumulating in vivo which had
originally led to the isolation of this mutant (Benghezal et al.,
1995) (Figure 3B). Further characterization of lipid f′ was
required since HF dephosphorylation showed that the correspon-
ding lipid f made by wild type microsomes contained intermedi-
ates with 0 or 1 Man only, whereas the in vivo made M2* of 839
had previously been shown to contain 2 Man residues (Benghezal
et al., 1995). Therefore, the abnormal GPI lipids of 839 generated
in vivo (M2*) or in vitro (f′) were isolated by two consecutive
rounds of preparative TLC and soluble head groups were
obtained using methanolic ammonia followed by PI-PLC as
described (Sipos et al., 1994). The head groups were then
fragmented by HF dephosphorylation and acetolysis as shown in
Figure 4. In addition to the M0 fragment obtained from lipid f
made by wild type microsomes, HF treatment of lipid f′ of 839
yielded an additional major fragment containing two Man (Figure
4A, lane 1). The same fragment was obtained from M2* made in
vivo in addition to Ins stemming from a major [3H]Ins-labeled
contaminant having copurified with M2*, probably lyso-PI
(Figure 4B, lane 1′). The result indicates that microsomes from
839 indeed accumulate the same abnormal GPI intermediate as
the intact mutant cell. Further analysis of f′ and M2* using
combinations of HF dephosphorylation and acetolysis confirmed
that one of the two Man of this intermediate was linked α1,6
(Figure 4, lanes 3, 5, 3′, 5′). Experiments with JBAM showed that
f′ and M2* contained an HF sensitive substituent on Man1 as
shown in Figure 4: JBAM done before HF (lanes 4, 4′) yielded a
Man1-GlcN-Ins fragment (M1) whereas JBAM after HF yielded
GlcN-Ins (M0) fragment (lanes 2, 2′). The treatment of head
groups in the order acetolysis, then JBAM, then HF (lanes 6, 6′)
showed that after removal of the α1,6-linked Man, the protected
Man was still present. We conclude that it is not the α1,6-linked
Man that carries the HF sensitive substituent. The presence of a
substituent on Man1 could be confirmed by a JBAM treatment of
the intact [3H]Ins-labeled M2* lipid from 839 cells. JBAM
treatment shifted the purified M2* to a slightly less polar position
but didn’t generate the GlcN-(acyl)PI intermediate (M0) ex-
pected for a PI-PLC-resistant GPI intermediate having two Man
but no other substituents (Figure 5, lane 2). The heterogeneity of
purified M2* is analogous to the one observed with purified
GlcN-(acyl)PI and is probably due to migration of the acyl chain
on the myo-inositol (Sipos et al., 1997).
Two types of HF-sensitive substituents on Man1 have been
described in the literature so far. Mammalian GPI proteins
invariably have been found to contain an additional EtN-P group
on the conserved carbohydrate core and in several cases the
linkage of this group has been determined and found to attach
EtN-P by a phosphodiester bond to the C2 of Man1 (Tse et al.,
E.Canivenc-Gansel et al.
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Fig. 4. Structural analysis of head groups of lipid f’ and M2*. (A)
Microsomes of 839 were labeled with UDP-[3H]GlcNAc, lipid f′ was purified
by preparative TLC and its head group was obtained. (B) 839 cells were
metabolically labeled with [3H]Ins; lipid M2* was purified, and its head
group was obtained as above. Acetolysis (Acetol.), JBAM, and HF treatments
were carried out in the order indicated at the bottom of each lane. After these
treatments, all samples were N-acetylated, desalted, and analyzed by TLC.
M0,  GlcNAc-Ins; M1, Man1-GlcNAc-Ins; M2, Man2-GlcNAc-Ins. Lipid f′
was contaminated with a lipid species giving rise to a M0 HF fragment (lane
1). M2* contained a major contaminant yielding Ins (probably lyso-PI). Note
that acetolysis is not always quantitative in conditions in which only
α1,6-glycosidic bonds are to be cleaved (Schneider et al., 1990).
Fig. 5. Analysis of the M2* glycolipid of gpi10. [3H]Ins-labeled M2* from
839 was purified as in Figure 4. After PI-PLC (lane 4), GPI-PLD (lane 3),
and JBAM (lane 2) the lipids were separated by TLC in solvent 1. A
nontreated control is shown in lane 1.
1985; Homans et al., 1988; Roberts et al., 1988b; Walter et al.,
1990; Stahl et al., 1992; Redman et al., 1994; Taguchi et al., 1994;
Fig. 6. Lipids from yeast strains metabolically labeled with [3H]EtN. W303
wild type (wt), FBY11 (gpi8–1), and FBY169 (gpi10–1) were metabolically
labeled with [3H]EtN or [3H]Ins at 37C. [3H]Ins-labeled (lanes 1, 2) or
[3H]EtN-labeled lipids (lanes 3, 4, 5) were separated by TLC with solvent 1.
Phosphatidylethanolamine (PE) and phosphatidylcholine (PC) were the main
[3H]EtN-labeled species. Arrowheads point to the abnormal lipids of
gpi10–1 cells.
Treumann et al., 1995). An additional EtN-P has also been found
in lower vertebrates (Mehlert et al., 1993) and in Dictyostelium
discoideum (Haynes et al., 1993). EtN-P on Man1 was found to
be present already at the level of the mammalian precursor
glycolipids (Hirose et al., 1992; Kamitani et al., 1992; Puoti and
Conzelmann, 1992; Ueda et al., 1993).
The other type of HF-sensitive substituent was found in the
GPI precursor glycolipids of Paramecium primaurelia and
consists of Man, again linked via a phosphodiester to Man1
(Azzouz et al., 1995).
In an attempt to elucidate the identity of the HF sensitive
substituent on Man1, we compared the lipid extract of [3H]EtN-
labeled 839 and wild type cells and found that 839 contains an
abnormal, [3H]EtN-labeled lipid in the same region as M2*,
which is not seen in wild type cells nor in CP2 accumulating gpi8
cells (Figure 6). This [3H]EtN-labeled lipid of 839 was sensitive
to GPI-PLD (not shown). These results strongly suggest that the
additional substituent on Man1 consists of EtN-P and that M2*
and lipid f′ accumulating in 839 have the structure
Manα1–6(EtN-P-)Manα1–4GlcNα1–6(acyl)Inositol-P-lipid.
GPI anchors of 839 contain four mannoses
Results showed that 839 incorporates [3H]Ins into proteins and is
able to make GPI anchored proteins in spite of the fact that its
microsomes are completely unable to add Man3. It therefore
Phosphoethanolamine side chain in yeast GPI glycolipids
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Fig. 7. Analysis of the GPI-anchor structure from W303 (lane 1) and
gpi10–1 (lane 2). Cells were labeled with [3H]Ins and GPI-anchored peptides
were obtained as described in Materials and methods. Anchor peptides were
subjected to HF treatment, N-acetylated, desalted, and separated by TLC.
M0 to M5, Man0-GlcNAc-Ins to Man5-GlcNAc-Ins.
seemed to be a possibility that the EtN-P on Man1 may serve as
an alternative attachment point for the GPI protein. To test for
this, we labeled 839 and wild type cells with [3H]Ins, prepared
anchor peptides from the labeled GPI proteins and treated them
with HF. As can be seen on Figure 7, 839 contains the same M4
and M5 fragments as wild type cells. A minor M2 fragment is
present in both, wild type and 839 cells but has not been observed
in previous experiments of the same type in wild type cells (Sipos
et al., 1995). The minor M2 fragment probably is due to some non
specific hydrolysis of glycosidic bonds during HF treatment in
this experiment.
We conclude that 839, in spite of the complete biosynthetic
block observed in vitro, is able to make complete anchor
precursor lipids in vivo. The GPI transamidase transferring the
GPI onto precursor proteins does not seem to be able to use the
accumulating M2* glycolipid as an alternative anchoring device,
at least not in a situation in which complete precursor lipids are
also available.
An HF sensitive substituent is also present on the
α1,4-linked Man of the complete GPI precursors
The presence of EtN on Man1 came as a surprise to us since
previous structural analysis of the GPI anchor of yeast proteins
had not unveiled any EtN-P residue on Man1 (Fankhauser et al.,
1993), although this analysis relied on methods which had
detected such a residue on the mammalian GPI anchor (Homans
et al., 1988). We therefore asked, if the addition of EtN-P to Man1
is a physiological event or if it only occurs under special
circumstances when an abnormal intermediate is accumulating,
as is the case in 839. For this we reinvestigated the structure of the
complete GPI precursors CP1 and CP2 of pmi40, a mutant with
a conditional defect (ts) in Man biosynthesis allowing for efficient
metabolic labeling of otherwise undetectable GPI lipids (Sipos et
al., 1994). At the same time we also analyzed M4*, a minor, less
polar GPI lipid of pmi40 which comigrates with the major
abnormal lipid accumulating in gpi7 (Benghezal et al., 1995)
(Figure 8, top). To assess the presence of an HF sensitive
substituent on Man1, the head groups of [3H]Man-labeled CPs
were first cleaved by acetolysis, a procedure which in mild
conditions specifically cleaves α1,6-glycosidic bonds (Figure 1).
Here this procedure is expected to produce the two fragments
Manα1,2(EtN-P-)Manα1,2Man and (X?-)Manα1,4GlcN-
α1,6Ins with X being the hypothetical substituent in question
(Figure 1). The fragments were then treated with JBAM or
control incubated and finally dephosphorylated by HF. The
resulting fragments were analyzed by paper chromatography. As
can be seen in Figure 8, the (X?-)Manα1,4GlcNα1,6Ins of CPs
is JBAM resistant since after HF we obtain Manα1,4GlcN-
α1,6Ins (M1) but the analogous fragment of M4* is JBAM
sensitive. Since JBAM treatment after HF reduces all fragments
to free Man and GlcN-Ins (not shown; Sipos et al., 1994), the
result clearly indicates that CPs contain an HF sensitive
substituent on Man1 which is not present on M4*. On the other
hand both CPs and M4* seem to contain an HF sensitive group
on Man3 since the residual M4 fragments which survived
acetolysis were degraded by JBAM to M3 not to M1 or M0
(Figure 8). The same conclusion can be reached by looking at the
Man4-Man3-Man2 (M-M-M) fragments generated by acetolysis:
they are not completely degraded by JBAM but are shifted to a
smaller fragment (M-M). From the presence of EtN-P on Man1
of M2* of 839, we infer that X on Man1 of CP2 most likely is also
an EtN-P.
Analysis of the dolichol-linked glycans
The biosynthesis of the Dol-PP-GlcNAc2-Man9-Glc3 precursor
for N-glycosylation involves the addition of four different
α1,2-linked Mans, two of which are added on the cytosolic side
from GDP-Man the other two being added on the lumenal side of
the ER from Dol-P-Man (Abeijon and Hirschberg, 1992). ALG9
encodes a putative α1,2-mannosyltransferase transferring Man
from Dol-P-Man to the Dol-PP-GlcNAc2-Man6 intermediate on
the lumenal side of the ER (Burda et al., 1996). This transfer
reaction is similar to the transfer of the Man3 in GPI biosynthesis
which presumably is operated by YGL142C: in both reactions
Man is transferred from Dol-P-Man and is added in α1,2 linkage
onto Man. YGL142C indeed shows a low degree of homology to
ALG9 (22.5% identity and 49.5% similarity over 555 amino
acids). Since the second lumenal ER α1,2-mannosyltransferase
for the synthesis of N-glycans is not yet identified, we analyzed
the profile of dolichol-linked oligosaccharides in gpi10–1. The
mutant showed a perfectly normal profile and in particular, there
was no accumulation of Dol-PP-GlcNAc2-Man7 or Dol-PP-
GlcNAc2-Man8 (data not shown). Thus, there is no indication that
YGL142C is involved in the addition of α1,2-linked Man during
N-glycan biosynthesis.
Discussion
The GPI core structure linking the protein to the lipid moiety is
identical amongst all eukaryotes, but the biosynthetic pathway for
its elaboration evolved in slightly different ways in different
organisms. The differences are of practical interest in that they
may allow to develop drugs against pathogenic protozoa such as
trypanosomes, leishmania, and malaria, protozoans in which the
E.Canivenc-Gansel et al.
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Fig. 8. Fragmentation of CPs (A, B) and M4* (C, D) using acetolysis,
JBAM and HF. [3H]Man-labeled GPI lipids from pmi40 cells were purified
by preparative TLC. CP1 and CP2 having the same head group (Sipos et al.,
1994) were pooled (CP), and similarly, a broad region containing lipids with
4 Man was united (M4*) as indicated at the top. Head groups were liberated,
subjected to acetolysis, and further treated as follows: (A, C) HF; (B, D)
JBAM, then HF. All fragments were N-acetylated, desalted and separated by
paper chromatography. The paper was cut into 1 cm wide strips, their
radioactivity was determined through scintillation counting. The position of
standards run in parallel on the same paper are indicated: M1 to M4, Man1-
to Man4-GlcNAc-Ins; M-M, Man3-Man2; and M-M-M, Man4-Man3-Man2.
DPM, Dolicholphosphomannose. It may be striking that the M-M-M
fragments are not prominent than the M1 fragments although they contain
three times more Man. However, we noted that the peracetylated
Man4-(EtN-P-)Man3-Man2, due to the presence of the hydrophilic EtN-P
group, is not efficiently extracted into chloroform after acetolysis and thus
gets partially lost during this procedure.
GPI proteins are highly abundant (McConville and Ferguson,
1993). One difference concerns the attachment of a fatty acid to
the myo-inositol, an event which seems to occur at a different
stage of biosynthesis in trypanosomes than in mammalian cells
(Güther and Ferguson, 1995; Doerrler et al., 1996). Another
notable variation is observed with respect to the EtN-P side chain
on Man1 which seems to be invariably present in mammalian GPI
proteins, but which is not added in T.brucei, nor L.major, nor
Plasmodium falciparum (McConville and Ferguson, 1993;
Gerold et al., 1994). Here we document the existence of an EtN-P
on Man1 of M2* as well as of CPs of yeast, i.e., the complete
precursor lipid. In contrast to other organisms, yeast does not
make GPIs in excess of what is needed for the anchoring of
proteins and the pool size of complete GPIs is extremely low. The
paucity of material only allowed for a partial structural analysis
of the [3H]Man-labeled CPs from pmi40 cells (Sipos et al., 1994).
During this previous analysis we therefore did not look for an
EtN-P side chain since the extensive structural analysis of the
anchor peptides from mature GPI proteins of yeast had not
revealed the presence of such an EtN-P side chain on Man1
(Fankhauser et al., 1993).
Here we present evidence for the existence of several GPI
precursor lipids containing the Man4-GlcN-Ins core. Microsomes
generated four such intermediates (Figure 3A, bands h–k), and
the reinvestigation of the [3H]Man-labeled GPI lipids of pmi40
made in vivo reveals two intermediates, M4* and CPs both having
an HF sensitive group on M3. The presence of EtN-P on Man1
of CPs but not M4* offers an explanation for the different
mobility of these two compounds in TLC.
The presence of EtN-P on Man1 opens the opportunity to
study the enzymes involved in the attachment of this residue in
S.cerevisiae and thus to obtain information which potentially is
relevant for the mammalian system. The mammalian Thy1-defic-
ent mutant cell line S1A-b being deficient in the PIG-B gene
(Takahashi et al., 1996) as well as gpi10–1 accumulate an
intermediate having the head group Manα1–6(EtN-
P-)Manα1–4GlcN1–6Ins (Puoti et al., 1991; Hirose et al., 1992)
indicating that EtN-P can be added to Man-1 before addition of
Man3 in both organisms. Thus, the similarity of the yeast with the
mammalian system may also extend to the order in which the
anchor components are added. It may be noteworthy that the
microsomal yeast in vitro system made several GPI intermediates
containing only 1 Man; nevertheless, digestion of the microsomal
lipid extract with JBAM did not lead to an increase of
GlcN-acyl-PI (M0) suggesting that the single Man in these
intermediates may already be protected by an EtN-P. Addition of
EtN-P onto Man1-GlcN-acylPI has also been claimed to occur in
mammalian cells (Hirose et al., 1992). In spite of the several
analogies between the yeast and the mammalian systems, there
seems to be a major discrepancy in that the EtN-P on Man1 is not
found on mature yeast GPI proteins although it is invariably
present in mammalian GPI proteins. The following possibilities
can be considered. (1) The previous analysis of yeast proteins
(Fankhauser et al., 1993) may have missed the EtN-P on Man1,
since the preparation of GPI anchor peptides in that study was a
relatively lengthy procedure during which some hydrolysis of
anchor components may have occurred. (2) M4* may be the only
GPI which is transferred onto proteins. In this case, CPs may
serve some other, yet unknown purpose. (3) CPs may be
transferred to proteins but the EtN-P may be removed from Man1
soon after transfer. EtN-P would therefore play a transient role
during biosynthesis and attachment of GPIs. The fatty acid
attached to the Ins of GPI anchors is a precedent for a component
with a transient function in GPI anchor biosynthesis. Preliminary
data indicate that an HF-sensitive group indeed can be found on
Man1 of certain GPI proteins. GPIs are not only anchoring
devices but they are recognized physiologically by numerous
proteins and enzymes. They are cleaved by GPI-specific phos-
pholipases, they represent high affinity binding sites for bacterial
toxins such as aerolysins and pertussis toxin as well as for
interleukin-1β and, at least in yeast, they are substrates for an
extracellular transglycosidation reaction, by which GPI proteins
get covalently attached to the β1,6-glycans of the cell wall (Davitz
et al., 1989; Fukushima et al., 1997; Kollar et al., 1997; Nelson
et al., 1997; Rossjohn et al., 1997). It will be of interest to study
the influence of the EtN-P side chain on Man1 on these events.
Comparison of YGL142C with its human homolog PIG-B
shows 30.5% identity and 57.4% conserved changes. As PIG-B,
YGL142C predicts a very hydrophobic protein with multiple
transmembrane domains. Apart from ALG9 there are two
additional open reading frames encoding for highly hydrophobic
proteins with 22.5% (YOR149C) and 20.1% (YNR030W)
identity with YGL142C. The hydrophobicity plot of YNR030W
is particularly similar to the one of YGL142C. All of these genes
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Fig. 9. PIG-B, YGL142C, and related yeast sequences share a common sequence motif. PIG-B and three yeast homologs were found through a BLAST search
and aligned using the pileup multiple alignment program of the GCG software package (http://gcg.ch.embnet.org:8080/htdocs). Conservative replacements are
listed below the consensus sequence; 100% identity is marked in black, 80% in gray; 60% identity and conservative substitutions are in light gray. The length of
the open reading frame is given on the left. X designates any amino acid; U indicates amino acids with unpolar side chains; pI, isoelectric point. Sequences and
pIs are taken from the YPD (http://quest7.proteome.com/YPDhome.html) or NCBI databases (http://www.ncbi.nlm.nih.gov/) except PIG-B (Takahashi et al., 1996).
contain a highly conserved motif which is intercalated between
two hydrophobic regions (Figure 9). A Blast search (Altschul et
al., 1990) shows that this “HXEXRF motif does not seem to be
present in any other yeast open reading frame. The extreme
hydrophobicity of YGL142C and PIG-B may be a general feature
of glycosyltransferases which use dolichol-linked hexoses as a
substrate. Indeed, ALG6 and ALG8, two α1,3-glucosyltransfer-
ases adding Glc from Dol-P-Glc onto the lumenally oriented
Dol-PP-GlcNAc2-Man9 intermediate as well as ALG3 which
adds Man from Dol-P-Man onto Dol-PP-GlcNAc2-Man5 (Aebi
et al., 1996) all are very hydrophobic proteins. All known proteins
involved in the transfer of dolichol-linked hexoses also have a
relatively high isoelectric point between 8.5 and 9.6 (Figure 9).
Previous experiments have shown that the N-terminal, cyto-
solic extension of PIG-B is not essential for its function
(Takahashi et al., 1996) but it seems difficult at present to predict
at what side of the membrane the active center of this protein is
localized. The homology with ALG9 may indicate that it is on the
lumenal side but the very hydrophobic character of this class of
transferases may indicate that they are additionally involved in
the transmembrane movement of the Dol-P-Man or Dol-P-Glc
substrates.
Further experiments hopefully will allow to better understand
the exact function and orientation of these proteins.
Materials and methods
Strains, growth conditions, and materials
Wild type S.cerevisiae strains were W303–1A (Mata ade2–1
can1–100 ura3–1 leu2–3,112 trp1–1 his3–11,15), W303–1B
(Matα ade2–1 can1–100 ura3–1 leu2–3,112 trp1–1 his3–11,15)
and X2180–1A (Mata lys–). GPI-mutants (Benghezal et al.,
1995) were FBY11 (Matα ade2–1 can1–100 ura3–1 leu2–3,112
trp1–1 his3–11,15 gpi8–1). The original mutant 839 which we
named FBY169 (Matα ade2–1 can1–100 ura3–1 leu2–3,112
trp1–1 his3–11,15 gpi10–1) and the out and back crossed strain
FBY618 (Matα trp1–1 gpi10–1). For labeling with [2–3H]Man
we used C4 (Mata leu2–3,112 ura3–52 pmi40) (Payton et al.,
1991). Maintenance and growth conditions have recently been
described previously (Benghezal et al., 1996).
Reagents were obtained from the following sources:
myo-[2–3H]inositol (15 Ci/mmol), uridine diphosphate-N-acetyl-
D-glucosamine [glucosamine-6–3H] (40 Ci/mmol), [1–3H]etha-
nolamine (30 Ci/mmol), and [2–3H]Man (20 Ci/mmol) were
from Anawa Trading SA (Zürich, Switzerland); EN3HANCE
from NEN (Hertfordshire, UK); 0.2-mm-thick silica gel 60 plates
(20 × 20 cm) and phenylmethylsulfonyl fluoride (PMSF) from
Merck (Darmstadt, Germany); nikkomycin Z from Calbiochem
(San Diego, CA); ATP, coenzyme A, GDP-mannose, lyticase, and
tunicamycin from Sigma (St. Louis, MO); leupeptin, pepstatin,
chymostatin, and antipain from Fluka (Buchs, Switzerland);
5-fluoroorotic acid (5-FOA) from Toronto Research Chemicals
Inc. (Ontario, Canada); ammonia in methanol (7 M) from Janssen
Chimica (Beerse, Belgium); zymolase 20T from Seikagaku Corp.
(Tokyo, Japan); jack bean-α-mannosidase from the Oxford
Glycosystems (Oxford, UK); mixed bed ion exchange resin
(AG-501-X8) from Bio-Rad Laboratories (Hercules, CA); phos-
phatidylinositol-specific phospholipase C (PI-PLC) from Boeh-
ringer Mannheim (Mannheim, Germany); 300-fold purified
GPI-phospholipase D (GPI-PLD) from bovine serum was a kind
gift of Dr. U. Brodbeck, University of Bern (Bern, Switzerland).
Plasmids
The pBF61 vector was constructed by PCR amplification of the
full length YGL142C sequence from genomic DNA with the
following primers: IIP-1F (5′-GCTGTCTGTTGCCTAAA-
GA-3′) starting 579 bp upstream of the start codon and IIP-2R
(5′-CACCCTTAAAGATGGACCT-3′) starting 359 bp down-
stream of the stop codon, using the Expand High Fidelity PCR
System from Boehringer Mannheim. The PCR fragment was
digested with PstI and StuI and subcloned into the PstI/SmaI site
of the YEplac195 multicopy vector (Gietz and Sugino, 1988).
pBF62 was prepared by subcloning the PstI/KpnI YGL142C
fragment of pBF61 into the multiple cloning site of the
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centromeric vector YCplac33 (Gietz and Sugino, 1988). To
construct pBF64 the same YGL142C fragment was ligated into
YIplac211 (Gietz and Sugino, 1988) digested with PstI/KpnI.
YGL142C including 514 and 111 bp of the 5′ and 3′ untranslated
regions, respectively, was amplified by PCR from genomic DNA
of gpi10–1 as it has been done for the wild type YGL142C by
using the Expand High Fidelity PCR System. Both strands of two
independent PCR reactions were sequenced for us by Microsynth
GmbH (Balgach, Switzerland).
Protoplast fusion
Fusion of the yeast strain FBY169 with X2180–1A was done as
described previously (Tsuboi, 1981) with the following modifica-
tions: cells were cultured at 24C and converted to protoplasts
with lyticase under gentle agitation during 30–60 min at 24C.
For fusion 5 × 108 protoplasts of each fusion partner were mixed.
Fused protoplasts were resuspended in 6 ml regeneration agar
(45C) (Hinnen et al., 1978) and poured onto selective plates.
Metabolic radiolabeling and lipid extraction
Cells were grown in SDCUA medium. Exponentially growing
cells were centrifuged, washed and resuspended in fresh SDCUA
medium for labeling at a density of 10 OD600 units/ml. Cells (2.5
OD600 units in 250 µl of SDCUA) were preincubated for 20 min
and labeled with [3H]Ins (5 µCi) for 120 min whereby the cells
were diluted 4-fold with SDCUA 40 min after the addition of
[3H]Ins. Labeling of cells with [3H]EtN was done as described
previously (Menon and Stevens, 1992) with a few minor
modifications: 10 OD600 of cells were resuspended in 1 ml of
SDCUA, preincubated for 10 min at 37C, 50 µCi of radiolabel
were added and cells incubated in a shaking water bath. After 2 h
cells were diluted with one volume of fresh medium and
incubated for 2 more hours. Strain C4 was labeled with
[2–3H]Man as described previously (Sipos et al., 1994). To stop
the labeling cells were placed on ice and NaN3 and NaF (10 mM
final) were added. Cells were washed with 1 M sorbitol at 4C.
Lipids were extracted and desalted by butanol extraction as
described previously (Sipos et al., 1994). Lipid extracts were
analyzed by ascending TLC using 0.2 mm thick silica gel 60
plates with the solvent 1 (chloroform/methanol/water; 10/10/3,
v/v/v) or solvent 2 (chloroform/methanol/0.25% KCl; 55/45/10,
v/v/v). Radioactivity was detected by two-dimensional radio-
scanning (LB 2842; Berthold AG, Regensdorf, Switzerland) or
else, TLC plates were sprayed with EN3HANCE and exposed for
fluorography at -80C.
Preparation of yeast membranes
Membranes were prepared as described previously (Goud et al.,
1988) from exponentially growing cell cultures in SDCUA
medium. Cells were converted to spheroplasts and homogenized
as described previously with the exception that the cells were
incubated for 1 h in 0.2 mg/ml of zymolase and spheroplasts were
broken by forcing them through a 0.4 × 19 mm syringe at 4C in
lysis buffer. Intact cells were eliminated by low speed centrifuga-
tion and membranes were obtained by two centrifugations at
15,000 × g for 30 min at 4C and resuspended at about 10 mg
protein/ml in lysis buffer (Goud et al., 1988).
Purification of GPI-peptides
GPI proteins were extracted and extensively delipidated with
organic solvents and were further delipidated by Concanavalin
A–Sepharose affinity chromatography; GPI peptides were ob-
tained by pronase digestion and purified over octyl-Sepharose
exactly as described previously (Sipos et al., 1997).
Biosynthesis of GPIs by microsomes in vitro
In vitro biosynthesis of GPIs using UDP-[3H]GlcNAc was
performed as described (Costello and Orlean, 1992). All reactions
were carried out at 37C and in a final volume of 100 µl. Aliquots
of freshly prepared membranes (100 µg protein/tube) were
diluted into 100 mM TRIS-HCl, pH 7.5, 1 mM EGTA, 3 mM
MgCl2, 0.5 mM MnCl2, 1 mM ATP, 1 mM Coenzyme A,
21 µg/ml tunicamycin, and 10 µM nikkomycin Z (to inhibit
utilization of UDP-GlcNAc by chitin synthases (Dähn et al.,
1976) and in some cases 1 mM GDP-Man. Membranes were
preincubated for 10 min at 37C and then transferred to a tube
containing 6 µCi dried UDP-[3H]-GlcNAc. After incubation for
1 h the reaction was stopped by the addition of 1 ml chloroform/
methanol (1/2, v/v). After thorough mixing and removal of
insoluble components by centrifugation, the supernatant was
saved and the pellet extracted a second time with 0.5 ml of solvent
1. The lipids from both extractions were pooled, dried and
partitioned between butanol and water to remove salts. Lipid
extracts were analyzed as mentioned above.
Structural analysis of GPIs
PI-PLC, GPI-PLD, and JBAM (jack bean α-mannosidase)
treatments were carried out at 37C following procedures
described previously (Puoti and Conzelmann, 1993; Davitz et al.,
1989; and Ralton et al., 1993, respectively).
Soluble head groups were obtained from purified glycolipids
or anchor-peptides through selective removal of acyl groups
attached to the Ins using methanolic NH3 (Roberts et al., 1988a)
followed by PI-PLC treatment in 20% propanol (Puoti and
Conzelmann, 1993). Fatty acids and lipids were removed by
butanol extraction. Head groups were subjected to hydrofluoric
acid (HF) dephosphorylation (Ferguson et al., 1988) and were
N-acetylated (Gopal and Ballou, 1987) and desalted using
mixed-bed ion exchange resin AG-501-X8 (Puoti and Conzel-
mann, 1992). Acetolysis and JBAM treatments were done as
described previously (Schneider et al., 1990).
N-Acetylated, water-soluble head group fragments were
separated by ascending TLC using 0.2-mm-thick silica gel 60
plates in four consecutive runs in butanol/ethanol/water (4/3/3,
v/v/v; Puoti and Conzelmann, 1993) and analyzed by fluoro-
graphy as described above or were separated by ascending paper
chromatography in methylketone/pyridine/water (20/12/11, v/
v/v) as described previously (Sipos et al., 1994).
Analysis of dolichol-linked oligosaccharides
Cells were labeled with [3H]Man, lipids were extracted, oligosac-
charides released and analyzed by HPLC exactly as described
previously (Zufferey et al., 1995).
Note added in proof
The mutant gene gpi10-1 (encoding Thr at position 48) and the
same gene corrected according to the wild type gene (encoding
Ala at position 48) were cloned into YCplac33 vector to generate
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pBF67 and pBF69, respectively. After transformation of gpi10-1
with these two plasmids, cells were labeled with 3H-Ins and the
lipids were analyzed. pBF67 does not abolish the M2* accumula-
tion of gpi10-1 whereas pBF69 does. This result demonstrates
that the mutation (Thr48) is responsible for the phenotype of M2*
accumulation in gpi10-1 cells.
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